CollPlant Biotechnologies Ltd - Ordinary Shares New
CLGN
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.76M
Close$
$-0.11
102.9% downside
Current Fair Value
102.9% downsideOvervalued by 102.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.76 Million |
|---|---|
| Enterprise Value | $4.47 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-9.4 |
| Beta | 0.76 |
| Outstanding Shares | 1,442,626 |
Return
| Return on Equity | -424.89% |
|---|---|
| Return on Assets | -173.86% |
| Return on Invested Capital | -262.81% |
Valuation & Multiples
| P/E Ratio | -0.39 |
|---|---|
| PEG | 2.11 |
| Price to Sales | - |
| Price to Book Ratio | 1.86 |
| Enterprise Value to Revenue | 14.05 |
| Enterprise Value to EBIT | -0.36 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.6 |
| Debt to Equity | 0.9 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
$-2.45
Average shareholder expectationRevenue Estimate
$480,000
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.53
Average shareholder expectationRevenue Estimate
$520,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%0% |
|---|---|
| Total Invested | $25▼ 34.21% |
| Investors Holding | 10% |
ESG Score
No data
About CollPlant Biotechnologies Ltd
CEO: Yehiel Tal